522.2063—Pyrilamine maleate injection.
(a) Specifications.
The drug is a sterile aqueous solution with each milliliter containing 20 milligrams of pyrilamine maleate.
(b) Sponsors.
See No. 000061 in § 510.600(c) of this chapter for uses in paragraph (c)(2)(i) of this section; see No. 061623 in § 510.600(c) of this chapter for uses in paragraph (c)(2)(ii) of this section.
(c) Conditions of use.
(1)
It is intended for treating horses in conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease. 1
Code of Federal Regulations
Footnote(s): 1 These conditions are NAS/NRC reviewed and found effective. Applications for these uses need not include effectiveness data as specified by § 514.111 of this chapter, but may require bioequivalency and safety information.
(2)
(i)
It is administered intramuscularly, subcutaneously, or intravenously. Local injection at the site of insect bites may be indicated in severe cases. Intravenous injections must be given slowly to avoid symptoms of overdosage. Dosage may be repeated every 6 to 12 hours whenever necessary. Horses, 40 to 60 milligrams per 100 pounds body weight; foals, 20 milligrams per 100 pounds body weight. 1
(ii)
It is administered intravenously. Intravenous injections must be given slowly to avoid symptoms of overdosage. Dosage may be repeated every 6 to 12 hours if necessary. Horses, 40 to 60 milligrams per 100 pounds body weight; foals, 20 milligrams per 100 pounds body weight. 1